Question 1

What is Myriad Genetics's deferred tax assets and other non-current assets?

Accepted Answer

Myriad Genetics (MYGN) reported deferred tax assets and other non-current assets of $5.6M in Q1 2026.

Question 2

How has Myriad Genetics's deferred tax assets and other non-current assets changed year-over-year?

Accepted Answer

Myriad Genetics's deferred tax assets and other non-current assets decreased by 27.3% year-over-year, from $7.7M to $5.6M.

Question 3

What is the long-term trend for Myriad Genetics's deferred tax assets and other non-current assets?

Accepted Answer

Over 5 years (2020 to 2025), Myriad Genetics's deferred tax assets and other non-current assets has grown at a 19.5% compound annual growth rate (CAGR), from $2.3M to $5.6M.

Line item	March 31,2026	December 31,2025
Property, plant and equipment, net	111.5	114.0
Intangible assets, net	145.7	153.4
Goodwill	47.1	51.6
Other assets	5.6	5.6
Total assets	$673.7	$706.6
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$32.6	$30.0

Deferred Tax Assets and Other Non-Current Assets at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Myriad Genetics's deferred tax assets and other non-current assets.

Myriad Genetics MYGN Deferred Tax Assets and Other Non-Current Assets